R&D | January 14, 2026
Codexis teams up with Axolabs to advance enzymatic RNA manufacturing
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The demand in Africa for COVID-19 vaccines has declined
The collaboration will support Canada with direct access to rapid pandemic response capabilities
Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ecosystem and strengthen health security
Hongene will focus on developing and scaling production of key capping reagents—essential components of mRNA therapeutics—emphasizing accessibility, transparency, and global deployment
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology
Subscribe To Our Newsletter & Stay Updated
